American Association for Cancer Research
Browse

Download Supplementary Movie File from Toward Molecular Imaging–Driven Drug Development in Oncology

Download (58.68 MB)
media
posted on 2023-04-03, 20:24 authored by Elisabeth G.E. de Vries, Thijs H. Oude Munnink, Marcel A.T.M. van Vugt, Wouter B. Nagengast
<p>Format: .mp4; Size: 59 MB.</p><p><b>Description of Movie</b></p><p> Many rapidly dividing tumor cells express or overexpress surface receptor molecules that can be targeted with antibodies. Tracers (for example, the radionuclide zirconium-89) can be attached to these antibodies and administered to patients. Once the antibody reaches the surface receptor on the tumor cell, it is internalized and digested in an endosome, releasing the tracer. Accumulation of the tracer in the tumor cells can then be visualized.</p><p>NOTE: There is no audio component associated with this video file.</p>

History

Related Materials

ARTICLE ABSTRACT

With current testing strategies, the number of novel targeted anticancer agents will exceed our drug selection capacity. Molecular imaging is a powerful additional tool that can assist us in selecting effective drugs and help patients benefit from targeted agents. Moreover, measurement of the functional effects of such targeted agents could permit dynamic tuning of treatment selection at the earliest time point at which loss of functional effects is observed. Cancer Discovery; 1(1); 25–8. ©2011 AACR.

Usage metrics

    Cancer Discovery

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC